Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
When Medical Patents Weaken Health Care
I-MAK’s Tahir Amin on Washington Business Tonight Discussing the Case Against Abbott’s Drug Kaletra
Tahir Amin Awarded Prestigious TEDIndia Fellowship for I-MAK’s Innovations, Accomplishments and Potential to Positively Affect the World
I-MAK’s Priti Radhakrishnan at Pop!Tech
I-MAK Director Chosen as NYU Law Alumni of the Month (November 2009)
I-MAK Director Selected to Asia 21 Summit in Malaysia
NYU Law Magazine profiles Priti Radhakrishnan
Scripnews.com covers Tahir Amin on expert patent review
India Rejects Gilead’s Tenofovir Patent Applications
The Treatment Timebomb